Viromed Medical AG Financial Flexibility Index
Viromed Medical AG financial flexibility index. Viromed Medical AG (Q11) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of €10.10 Million (operating CF €-10.12 Million minus capex €20.22 Million) represents 0% of total liabilities (€69.84 Million). See Viromed Medical AG free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Viromed Medical AG (2021–2024)
Financial flexibility index of Viromed Medical AG from 2021 to 2024. Historical Financial Flexibility Index trend for Viromed Medical AG across 4 annual periods. Explore Q11 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Viromed Medical AG Financial Flexibility Index by Year (2021–2024)
Viromed Medical AG financial flexibility index by year from 2021 to 2024. Year-by-year free cash flow to debt coverage for Viromed Medical AG. For the full cash flow conversion analysis, see Q11 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.92x | €105.40 Million | €-6.03 Million | €54.82 Million | ▲ +938.3% |
| 2023 | -0.23x | €-9.85 Million | €-34.16 Million | €42.96 Million | ▲ +97.9% |
| 2022 | -11.00x | €-20.55 Million | €-20.87 Million | €1.87 Million | ▼ -197.1% |
| 2021 | -3.70x | €-10.41 Million | €-22.29 Million | €2.81 Million | — |